Literature DB >> 29421308

HMGB1-mediated DNA bending: Distinct roles in increasing p53 binding to DNA and the transactivation of p53-responsive gene promoters.

Michal Štros1, Martin Kučírek2, Soodabeh Abbasi Sani2, Eva Polanská2.   

Abstract

HMGB1 is a chromatin-associated protein that has been implicated in many important biological processes such as transcription, recombination, DNA repair, and genome stability. These functions include the enhancement of binding of a number of transcription factors, including the tumor suppressor protein p53, to their specific DNA-binding sites. HMGB1 is composed of two highly conserved HMG boxes, linked to an intrinsically disordered acidic C-terminal tail. Previous reports have suggested that the ability of HMGB1 to bend DNA may explain the in vitro HMGB1-mediated increase in sequence-specific DNA binding by p53. The aim of this study was to reinvestigate the importance of HMGB1-induced DNA bending in relationship to the ability of the protein to promote the specific binding of p53 to short DNA duplexes in vitro, and to transactivate two major p53-regulated human genes: Mdm2 and p21/WAF1. Using a number of HMGB1 mutants, we report that the HMGB1-mediated increase in sequence-specific p53 binding to DNA duplexes in vitro depends very little on HMGB1-mediated DNA bending. The presence of the acidic C-terminal tail of HMGB1 and/or the oxidation of the protein can reduce the HMGB1-mediated p53 binding. Interestingly, the induction of transactivation of p53-responsive gene promoters by HMGB1 requires both the ability of the protein to bend DNA and the acidic C-terminal tail, and is promoter-specific. We propose that the efficient transactivation of p53-responsive gene promoters by HMGB1 depends on complex events, rather than solely on the promotion of p53 binding to its DNA cognate sites.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA bending; DNA-protein interaction; HMGB; Promoter transactivation; p53

Mesh:

Substances:

Year:  2018        PMID: 29421308     DOI: 10.1016/j.bbagrm.2018.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  5 in total

Review 1.  Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy.

Authors:  Haonan Dong; Lu Zhang; Suling Liu
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

Review 2.  Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy.

Authors:  Anirban Mukherjee; Karen M Vasquez
Journal:  Cancer Res       Date:  2020-03-09       Impact factor: 12.701

Review 3.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

Review 4.  Functional Diversity of Non-Histone Chromosomal Protein HmgB1.

Authors:  Elena Chikhirzhina; Tatyana Starkova; Anton Beljajev; Alexander Polyanichko; Alexey Tomilin
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

5.  The HMGB Protein KlIxr1, a DNA Binding Regulator of Kluyveromyces lactis Gene Expression Involved in Oxidative Metabolism, Growth, and dNTP Synthesis.

Authors:  Agustín Rico-Díaz; Aída Barreiro-Alonso; Cora Rey-Souto; Manuel Becerra; Mónica Lamas-Maceiras; M Esperanza Cerdán; Ángel Vizoso-Vázquez
Journal:  Biomolecules       Date:  2021-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.